* Note: Prices are in Million (M) USD.
Description:
AdaptHealth Corp. The company is headquartered in Plymouth Meeting, Pennsylvania.
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $110 M
Debt : $2,130 M
EBITDA : $640 M
Net Debt (Debt - Cash): $2,021 M
Since EBITDA cannot cover net debt within 3 years, Avoid This Stock.
This criteria used industry in which company operates:
Sector: Health Care
Industry: Medical Devices
Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 10.78
Since Forward PE Ratio is less than 15, 5 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Average Free Cash Flow: $84 M
Average Revenue: $1,576 M
Revenue Converted To Free Cash Flow (%): 5%
Avg Free Cash Flow Growth Per Year (Last 5 Years): 220.26%
Since Free Cash Flow (FCF) to Revenue percentage is less than 15, 1 point assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $3,261 M
Revenue 4 Years Ago (2020-12-31): $1,056 M
Last 5 Years Average Revenue Growth: 42%
Since Revenue Growth is greater than 20, 5 points assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-12-31): $136 M
Share Count 5 Years Ago (2020-12-31): $52 M
Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Next Year Earnings Per Share (EPS): $1.10
Trailing 12-Month Earnings Per Share (EPS): $0.64
Average Earnings Per Share (EPS): $0.87
Dividend Per Share (DPS): $0
Payout Ratio: 0%
Dividend Yield: 0%
Since Dividend Per Share is less than or equal to 0, 0 point assigned.
Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Average ROE: -7%
Since Average ROE is negative, 0 point assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $9
52-Week Low: $7
Threshold Price (15% Above 52-Week Low): $8
Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $1,232 M
Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Based on the market cap, we recommend do not exceed 2% exposure of Total Portfolio.
Value-Trade has assigned 15 points to above Adapthealth Corp (AHCO) stock.
Last 1 Years Avg PE (Limited to last 1 years of EPS data) 13.94, Fair Value PE 12, Industry Based PE is 18 and Growth based PE is 20. Based on these all values average assigned is 15.99.
Value-Trades has assined P/E value 15.99. Since an average (Current Year EPS + Next Year EPS) earning per share is $0.87.
The fair value of Adapthealth Corp (AHCO) stock should be (15.99 x $0.87) = $13.91
